Embody vs Gala: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Embody beats Gala overall, scoring 7.3/10 vs 7/10. Gala is more affordable at $149/mo vs $299/mo. Choose Embody for users looking for the lowest entry price with round-the-cloc. Choose Gala for users who want low-cost compounded tirzepatide and a built-i.
A side-by-side comparison of Embody and Gala covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#33 of 42Compounded tirzepatide provider offering both injectable and oral dissolvable gum formats — the only tracked platform with a non-injectable tirzepatide option. $149 first month includes medication, metabolic report, and 1:1 guidance; $299/mo for ongoing refills.
Visit EmbodyGala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit Gala| Feature | Embody | Gala |
|---|---|---|
| Our Score | 7.3/10 | 7/10 |
| Starting Price | $299/mo | $149/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users looking for the lowest entry price with round-the-clock specialist support | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging |
| Ranking | #33 | #40 |
Pros & Cons Compared
Embody
Pros
- +$149 first month is one of the lowest entry prices in the GLP-1 market — includes medication, metabolic report, and 1:1 guidance
- +Oral tirzepatide gum format available — one of the few platforms offering a non-injectable tirzepatide option for needle-phobic patients
- +24/7 specialist support included at no extra cost for questions about dosing, side effects, and progress
- +Personalized metabolic report helps you understand your body's baseline before starting treatment
Cons
- −Monthly refill price jumps to $299/mo after the first month — nearly double what competitors like Mochi ($99/mo + membership) or TrimRx ($179/mo) charge
- −Compounded medications only — no brand-name Wegovy or Zepbound available through the platform
- −Limited company transparency — founding date, headquarters, and pharmacy partners are not publicly disclosed
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Our Verdict
Embody edges out Gala with a score of 7.3/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to Embody's $299/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: users looking for the lowest entry price with round-the-clock specialist support. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging.